Skip to content
value.today

Seahorse Bioscience Inc.

Total raised
$11 M
1 round on record
Latest round
$11 M
May 2012
First round on record
May 2012
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Seahorse Bioscience Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2012$11 MNo. 1$10 to $50 million

Seahorse Bioscience Inc.: Raise no. 1, May 2012

Investors in this round

29 investors had bought by the notice of Apr 1, 2013: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Neilson · Executive Officer
  • David Ferrick · Executive Officer
  • James Orrell · Executive Officer
  • Jay Teich · Executive Officer, Director
  • Steve Chomicz · Executive Officer
  • Steven Young · Executive Officer
  • David Stone · Director
  • Earl Lewis · Director
  • Fouad Azzam · Director
  • Harry Wilcox · Director
  • Jeffrey Hurst · Director
  • Joseph Keegan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Each investor also received a warrant to purchase 1/4 share of Series E stock for each share of Series E stock purchased.”

Signed by Jay Teich, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 1, 2013. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Seahorse Bioscience Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2013).

    SEC Form D · Apr 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2013

That is all the official record says: Seahorse Bioscience Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Seahorse Bioscience Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 29 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Seahorse Bioscience Inc.
NameRoleNamed in
Andrew NeilsonExecutive officerApr 2013
David FerrickExecutive officerApr 2013
James OrrellExecutive officerApr 2013
Jay TeichExecutive officerApr 2013
Steve ChomiczExecutive officerApr 2013
Steven YoungExecutive officerApr 2013
David StoneDirectorApr 2013
Earl LewisDirectorApr 2013
Fouad AzzamDirectorApr 2013
Harry WilcoxDirectorApr 2013
Jay TeichDirectorApr 2013
Jeffrey HurstDirectorApr 2013
Joseph KeeganDirectorApr 2013